Results 21 to 30 of about 25,223 (248)

Defining the Differences Between Episodic Migraine and Chronic Migraine [PDF]

open access: yesCurrent Pain and Headache Reports, 2011
Chronic migraine (CM) and episodic migraine (EM) are part of the spectrum of migraine disorders, but they are distinct clinical entities. Population-based studies have shown that those with CM demonstrate higher individual and societal burden because they are significantly more disabled than those with EM and have greater impaired quality of life both ...
Katsarava, Zaza   +3 more
openaire   +2 more sources

Pain perception and migraine [PDF]

open access: yes, 2018
Background: It is well-known that both inter-and intra-individual differences exist in the perception of pain; this is especially true in migraine, an elusive pain disorder of the head.
Coppola, Gianluca   +6 more
core   +1 more source

Cerebral venous hemodynamic abnormalities in episodic and chronic migraine [PDF]

open access: yes, 2016
Alterations of cerebral venous drainage have been demonstrated in chronic migraine (CM), suggesting that cerebral venous hemodynamic abnormalities (CVHAs) play a role in this condition.
Di Biase, A   +7 more
core   +1 more source

Self-reported muscle pain in adolescents with migraine and tension-type headache [PDF]

open access: yes, 2012
Aim: To identify possible associations between muscular pain and headache in adolescents in a large population-based sample. Methods: Grammar school students were invited to fill in a questionnaire on headache and associated lifestyle factors.
Blaschek, Astrid   +9 more
core   +1 more source

The Integrative Migraine Pain Alleviation through Chiropractic Therapy (IMPACT) trial: Study rationale, design and intervention validation

open access: yesContemporary Clinical Trials Communications, 2020
Introduction: Approximately 15% of the US population experiences migraine, with women afflicted three times as often as men. While medications are often used as first-line treatments, up to 50% of people with migraine pursue complementary and integrative
P.M. Wayne   +8 more
doaj   +1 more source

Episodic neurologic disorders: syndromes, genes, and mechanisms. [PDF]

open access: yes, 2013
Many neurologic diseases cause discrete episodic impairment in contrast with progressive deterioration. The symptoms of these episodic disorders exhibit striking variety.
Fu, Ying-Hui   +2 more
core   +2 more sources

Regional volume changes of the brain in migraine chronification

open access: yesNeural Regeneration Research, 2020
The pathophysiology of migraine is complex. Neuroimaging studies reveal functional and structural changes in the brains of migraine patients. We sought to explore regional volume differences in intracranial structures in patients with episodic and ...
Xiao-Yan Chen   +4 more
doaj   +1 more source

Impact of the botulinum-A toxin on prevention of adult migraine disorders [PDF]

open access: yesJournal of Integrative Neuroscience, 2020
A systematic review of the impact of botulinum-A toxin as a therapeutic regimen for the management of adult migraine disorders is shown to that Botulinum-A toxin provides a more significant reduction in the number of headache episodes per month relative ...
Bin Shen, Lan Wang
doaj   +1 more source

11th European Headache Federation Congress jointly with 31st Congress of the Italian Society for the Study of Headaches : Rome, Italy. 01-03 December 2017 [PDF]

open access: yes, 2017
. Aims of the study were explore the relationship between peripheral chromatic and central visual dysfunction evaluating also the presence of functional receptor impairment in patients with migraine, with and without aura examined ...
Brighina, F   +5 more
core   +1 more source

A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine. [PDF]

open access: yes, 2017
BackgroundDFN-02 is a novel intranasal spray formulation composed of sumatriptan 10 mg and a permeation-enhancing excipient comprised of 0.2% 1-O-n-Dodecyl-β-D-Maltopyranoside (DDM).
Allenby, Kent   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy